Vistin Pharma

Company Description

---

We are a Norwegian pharmaceutical company. As a dedicated European producer of high quality Metformin, we are well positioned to supply the growing global market.

Vistin Pharma today produce about 10% of the world’s demand for Metformin HCl API and have in 2022 initiated a project to double the manufacturing capacity. Our Metformin is also available as direct compressible lubricated granules. Vistin Pharma Headquarter is located in Oslo, Norway. Our manufacturing facility is located in Kragerø, Norway. The facility is certified according to current Good Manufacturing Practice (cGMP) and successfully inspected by the US Food and Drug Administration (FDA).

Vistin Pharma AS was established in June 2015, when Vistin Pharma AS acquired the B2B business of Weifa AS.

Year founded

---

2015

Served area

---

Worldwide

Headquarters

---

Postboks 6735 Etterstad, 0609 Oslo – Norway

Shares outstanding

---

44,344,592

IPO

---

Oct. 3, 2018

Stock exchange(s)

---

Euronext Oslo